This Biotech Startup Just Raised $47 Million To Make Drugs From Fungi

In order to find the next penicillin, Menlo Park-based startup Hexagon Bio uses an AI platform to sequence the genomes of fungi.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive